She was born in the city of Lastrup in 1967 as a child of an immigrant family from Istanbul.
1995 German Society of Hematology and Oncology - Vincenz Czerny Prize
1997 Calogero Pagliarello Research Award.
She continued her work in the company she founded with Uğur Şahin in 2001 and named "Ganymed", inspired by the Turkish word "ganimet".
Period: to
He moved to Mainz in 2001. At the Mainz University Hospital, he conducted studies aiming to fight the immune system against cancer with modified genetic codes.
She married her colleague Uğur Şahin, who is also an immigrant from Turkey, in 2002.
2005 German Society of Immunology - Georges Köhler Award
Türeci founded BioNTech in 2008 with his wife Uğur Şahin and Austrian immunologist, oncologist Christoph Huber.
Ganymed, a pioneer in sensitive antibody therapies for cancer, was sold to Japanese pharmaceutical company Astellas in 2016.
She became the company's chief medical officer in 2018.
The company, which has 1300 employees as of 2020, initially worked on immunotherapy cancer treatments.
With the emergence of the COVID-19 pandemic in 2020, the company turned to finding a coronavirus vaccine.
Collaborating with BioNTech on the development of the vaccine, the US pharmaceutical company Pfizer announced on November 9, 2020 that the produced COVID-19 vaccine (BNT162) has achieved success.
